Sam Tomy K/ LinkedIn
Jun 5, 2026, 02:29
Sam Tomy K.: Antinuclear Antibody Testing and Its Role in Autoimmune Disease Diagnosis
Sam Tomy K, Laboratory Technician at MVR Cancer Centre and Research Institute, shared a post on LinkedIn:
“Understanding the ANA Test — A Key Marker in Autoimmune Diagnostics
The Antinuclear Antibody (ANA) test plays a crucial role in detecting autoimmune disorders such as lupus, Sjögren syndrome, systemic sclerosis, and mixed connective tissue disease.
In the laboratory, ANA testing by indirect immunofluorescence on HEp-2 cells remains the gold standard for identifying autoantibodies and interpreting fluorescence patterns.
Key highlights:
- ANA patterns and their clinical significance
- HEp-2 cell indirect immunofluorescence
- Titer interpretation
- Common autoimmune associations
- Importance of quality control in ANA testing
As medical laboratory professionals, understanding the science behind ANA testing helps improve diagnostic accuracy and patient care.”

Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI